Cargando…
Management of Hepatitis C Antiviral Therapy Adverse Effects
Hepatitis C is one of the leading causes of liver disease in the United States, affecting more than 4 million individuals. The current treatment regimen involves pegylated interferon in combination with ribavirin. Although antiviral treatment has been associated with a greater than 50% sustained vir...
Autores principales: | Sung, Hubert, Chang, Michael, Saab, Sammy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3030745/ https://www.ncbi.nlm.nih.gov/pubmed/21423320 http://dx.doi.org/10.1007/s11901-010-0078-7 |
Ejemplares similares
-
Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States
por: Saab, Sammy, et al.
Publicado: (2016) -
Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy
por: Saab, Sammy
Publicado: (2015) -
Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017) -
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
por: Suraweera, Duminda, et al.
Publicado: (2016) -
Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect?
por: Elsayed, Amr, et al.
Publicado: (2020)